|
English
|
正體中文
|
简体中文
|
Total items :2851802
|
|
Visitors :
44728798
Online Users :
1321
Project Commissioned by the Ministry of Education
Project Executed by National Taiwan University Library
|
|
|
|
Taiwan Academic Institutional Repository >
Browse by Author
|
"黃志富"
Showing items 76-100 of 110 (5 Page(s) Totally)
<< < 1 2 3 4 5 > >>
View [10|25|50] records per page
| 高雄醫學大學 |
2007 |
Human leukocyte antigen class I and II alleles and response to peginterferon plus ribavirin combination therapy in chronic hepatitis C patients
|
莊萬龍;戴嘉言;謝明彥;黃志富;張文宇;余明隆 |
| 高雄醫學大學 |
2007 |
The Seroprevalence Of HBV And HCV Infection In Southern Taiwan- Large Scale Community-Based Study
|
莊萬龍;余明隆;戴嘉言;林嘉益;侯乃仁;李立柏;謝明彥;黃志富;謝明裕;張文宇 |
| 高雄醫學大學 |
2007 |
Transforming Growth Factor-Beta 1 Gene Polymorphisms In High Dose IFN/Ribavirin treated CHC Patients
|
戴嘉言;余明隆;張文宇;李立柏;潘文正;侯乃仁;謝明彥;黃志富;陳信成;林子堯;謝明裕;王良彥;莊萬龍 |
| 高雄醫學大學 |
2007 |
Early Mortality And Responses In Non-Cirrhotic Decompensated CHB Patients With Lamivudine Therapy
|
戴嘉言;余明隆;侯乃仁;謝明彥;李立柏;黃志富;陳信成;王良彥;張文宇;莊萬龍 |
| 高雄醫學大學 |
2007 |
EARLY MORTALITY AND RESPONSES IN NON-CIRRHOTIC PATIENTS WITH CHRONIC HEPATITIS B-RELATED DECOMPENSATION WITH LAMIVUDINE THERAPY: EVALUATION OF MELD AND INDEX SCORING SYSTEMS AS PROGNOSTIC PREDICTORS
|
戴嘉言;余明隆;侯乃仁;謝明彥;李立柏;黃志富;林子堯;陳信成;謝明裕;王良彥;張文宇;莊萬龍 |
| 高雄醫學大學 |
2007 |
The presence of Antinuclear Antibody is associated with a negative response to combination therapy with peginterferon and ribavirin for patients without genotype 1 chronic hepatitis C infection
|
謝明彥;戴嘉言;黃志富;莊萬龍;侯乃仁;李立柏;陳信成;謝明裕;王良彥;張文宇;余明隆 |
| 高雄醫學大學 |
2007 |
Pretreatment insulin sensitivity contributes to the treatment response to peginterferon plus ribavirin combination therapy for patients with chronic hepatitis C
|
黃志富;余明隆;戴嘉言;張文宇;莊萬龍 |
| 高雄醫學大學 |
2007 |
CLINICAL EVALUATION OF THE ABBOTT REAL-TIME PCR ASSAY FOR QUANTIFICATION OF HEPATITIS C VIRUS INFECTION AMONG GENOTYPE-1 AND -2 PATIENTS IN TAIWAN- COMPARISON TO THE VERSANT HCV RNA 3.0 ASSAY
|
戴嘉言;黃志富;余明隆;莊萬龍;張文宇 |
| 高雄醫學大學 |
2007 |
High chance of cure in HCV genotype 1 patients with a low viral load achieving an RVR treated for 24 wks with pegylated interferon alfa-2a (PEGASYS) plus ribavirin (COPEGUS): Prospective, randomized, controlled study comparing 24 & 48 wks of treatm
|
余明隆;戴嘉言;黃志富;李立柏;謝明彥;丘長富;侯乃仁;林子堯;陳信成;謝明裕;王良彥;張文宇;莊萬龍* |
| 高雄醫學大學 |
2007 |
PHARMACOGENOMICS STUDY FOR 24 VS. 48 WEEKS TREATMENT OF PEGINTERFERON PLUS RIBAVIRIN FOR GENOTYPE 1b CHRONIC HEPATITIS C
|
戴嘉言;黃志富;謝明彥;陳信成;余明隆;莊萬龍 |
| 高雄醫學大學 |
2007 |
RELATIONSHIP BETWEEN GLUCOSE ABNORMALITIES AND RESPONSE TO PEGYLATED INTERFERON ALFA PLUS RIBAVIRIN COMBINATION THERAPY IN CHRONIC HEPATITIS C PATIENTS
|
謝明彥;戴嘉言;黃志富;林子堯;余明隆;莊萬龍 |
| 高雄醫學大學 |
2007 |
PRETREATMENT INSULIN RESISTANCE WAS ASSOCIATED WITH RESPONSE TO COMBINATION THERAPY WITH PEGYLATED INTERFERON ALFA AND RIBAVIRIN IN NON-DIABETIC PATIENTS WITH CHRONIC HEPATITIS C
|
余明隆;戴嘉言;黃志富;李立柏;王良彥;莊萬龍 |
| 高雄醫學大學 |
2007 |
CHARACTERISTICS OF GLUCOSE ABNORMALITIES AMONG PATIENTS WITH CHRONIC HEPATITIS C INFECTION
|
黃志富;戴嘉言;李立柏;王良彥;莊萬龍 |
| 高雄醫學大學 |
2007 |
Hepatocellular carcinoma presented as a liver abscess
|
黃駿逸;王良彥;黃志富;莊萬龍 |
| 高雄醫學大學 |
2007 |
Underestimation of glucose abnormalities among patients with chronic hepatitis C infection
|
黃志富;余明隆;戴嘉言;辛錫璋;張文宇;莊萬龍 |
| 高雄醫學大學 |
2007 |
台灣慢性C型肝炎病患葡萄糖耐受異常之特徵
|
黃志富;戴嘉言;莊萬龍;張文宇 |
| 高雄醫學大學 |
2006 |
Outcome of chronic hepatitis C patients who required early termination of pegylated interferon-alpha plus ribavirin combination therapy.
|
余明隆;戴嘉言;李立柏;謝明彥;侯乃仁;黃志富;林子堯;陳信成;謝明裕;王良彥;張文宇;莊萬龍 ; Yu ML;Dai CY;Lee LP;Hsieh MY;Hou NJ;Huang JF;Lin ZY;Chen SC;Hsieh MY;Wang LY;Chang WY;Chuang WL |
| 高雄醫學大學 |
2006 |
The role of thyroid autoantibodies in the development of thyroid dysfunction in Taiwanese chronic hepatitis C patients with interferon-alpha and ribavirin combination therapy.
|
黃志富;莊萬龍;戴嘉言;陳信成;林子堯;李立柏;王良彥;謝明裕;張文宇;余明隆 ; Jee-Fu Huang;Wan-Long Chuang;Chia-Yen Dai;Shinn-Cherng Chen;Zu-Yau Lin;Li-Po Lee;Liang-Yen Wang;Ming-Yuh Hsieh;Wen-Yu Chang;Ming-Lung Yu |
| 高雄醫學大學 |
2006 |
Tumor necrosis factor- alpha promoter polymorphism at position -308 predicts response to combination therapy in hepatitis C virus infection.
|
戴嘉言;莊萬龍;張文宇;陳信成;李立柏;謝明彥;侯乃仁;林子堯;黃志富;謝明裕;王良彥;余明隆 ; Dai CY;Chuang WL;Chang WY;Chen SC;Lee LP;Hsieh MY;Hou NJ;Lin ZY;Huang JF;Hsieh MY;Wang LY;Yu ML |
| 高雄醫學大學 |
2006 |
SEN and hepatitis virus infections in nontransfused children and pediatric thalassemia patients with multiple transfusions in Taiwan
|
邱世欣;黃志富;張泰琮;謝明彥;戴嘉言;張文宇;莊萬龍 ; Chiou, SS;Huang, JF;Chang, TT;Hsieh, MY;Dai, CY;Yu, ML;Chang, WY;WL , Chuang |
| 高雄醫學大學 |
2006 |
Viral hepatitis and proteinuria in an area endemic for hepatitis B and C infections: another chain of link?
|
黃志富;莊萬龍;戴嘉言;何啟功;黃尚志;陳信成;林子堯;王良彥;張文宇; , 余明隆; Huang, JF;Chuang, WL;Dai, CY;Ho, CK;Hwang, SJ;Chen, SC;Lin, ZY;Wang, LY;Chang, WY; , Yu ML |
| 高雄醫學大學 |
2006 |
HEPATITIS C VIREMIA INCREASES PREVALENCE OF NON-INSULIN-DEPENDENT DIABETES MELLITUS IN A HEPATITIS B AND C ENDEMIC AREA
|
黃志富;莊萬龍;戴嘉言;何啟功;張文宇;余明隆 |
| 高雄醫學大學 |
2006 |
A randomized study of peginterferon and ribavirin for 16 vs 24 weeks in patients with genotype 2 chronic hepatitis C
|
余明隆;戴嘉言;黃志富;侯乃仁;李立柏;謝明彥;丘長富;林子堯;陳信成;謝明裕;王良彥;張文宇;莊萬龍 |
| 高雄醫學大學 |
2006 |
Predictors for early mortality in lamivudine-treated patients with chronic hepatitis B-related decompensation in Taiwan ”has been accepted for poster presentation at the forthcoming.
|
戴嘉言;莊萬龍;李立柏;謝明裕;侯乃仁;陳信成;林子堯;謝明彥;王良彥;黃志富;張文宇;余明隆 |
| 高雄醫學大學 |
2006 |
A randomized, controlled, open-label study of peginterferon alfa-2a (40KD) (PEGASYS®) plus ribavirin (COPEGUS®) for 16 vs. 24 weeks in patients with genotype 2 hepatitis C infection
|
余明隆;黃志富;侯乃仁;李立柏;謝明彥;丘長富;林子堯;陳信成;謝明彥;王良彥;張文宇;莊萬龍 |
Showing items 76-100 of 110 (5 Page(s) Totally)
<< < 1 2 3 4 5 > >>
View [10|25|50] records per page
|
